Which contraceptive side effects matter most? Evidence from current and past users of injectables and implants in Western Kenya.
Care-seeking
Implants
Injectables
Kenya
Satisfaction
Side effects
Journal
Contraception: X
ISSN: 2590-1516
Titre abrégé: Contracept X
Pays: United States
ID NLM: 101767748
Informations de publication
Date de publication:
2020
2020
Historique:
received:
06
03
2020
revised:
09
06
2020
accepted:
10
06
2020
entrez:
10
7
2020
pubmed:
10
7
2020
medline:
10
7
2020
Statut:
epublish
Résumé
The objectives were to assess experiences of menstrual bleeding and nonbleeding side effects among current and past users of injectables and implants and the associations between side effects and method evaluations by women - satisfaction, perceived suitability, the likelihood of future use and intended duration of use. We used data on past and current users of injectables and implants from a survey of 1866 married or cohabiting women who participated in the third round of a 2-year prospective longitudinal study conducted in Homa Bay County, Western Kenya. Descriptive and bivariate analysis with Self-reported method-related bleeding problems were high among current and past users of injectables (range 69%-79%) and implants (range 55%-60%) and much more common than nonbleeding side effects. For both methods, experience of either bleeding or nonbleeding side effects reduces positive evaluations, but the conjunction of both types had particularly pronounced consequences. Heavy bleeding was more strongly related to method evaluation (satisfaction and the likelihood of future use; p < .001) among past users than other forms of menstrual bleeding disorders. Even among current users, about one third regarded bleeding side effects as very serious. Care-seeking from a healthcare provider for management of contraceptive-related side effects was low among current users (less than 40%) and modest among past users (range 53%-63%). The results underscore the need to strengthen programs on counseling and information on contraceptive side effects including menstrual bleeding disturbances to improve method satisfaction and reduce discontinuation. The experience of contraceptive-related menstrual bleeding and nonbleeding side effects reduces positive evaluation of the method and deters past users from future use of the method.
Identifiants
pubmed: 32642642
doi: 10.1016/j.conx.2020.100030
pii: S2590-1516(20)30013-7
pii: 100030
pmc: PMC7332521
doi:
Types de publication
Journal Article
Langues
eng
Pagination
100030Informations de copyright
© 2020 The Authors.
Références
Contraception. 2009 May;79(5):356-62
pubmed: 19341847
Int Perspect Sex Reprod Health. 2011 Mar;37(1):16-23
pubmed: 21478084
Reprod Health. 2017 Feb 9;14(1):23
pubmed: 28183308
J Biosoc Sci. 2019 Jul;51(4):491-504
pubmed: 30309402
Int Perspect Sex Reprod Health. 2013 Sep;39(3):133-41
pubmed: 24135045
J Sex Res. 2005 Nov;42(4):324-34
pubmed: 19827237
PLoS One. 2018 Nov 7;13(11):e0199724
pubmed: 30403671
Psychosom Med. 2011 Sep;73(7):598-603
pubmed: 21862825
Best Pract Res Clin Obstet Gynaecol. 2014 Aug;28(6):795-806
pubmed: 24996766
Eur J Contracept Reprod Health Care. 2008 Jun;13 Suppl 1:13-28
pubmed: 18330814
Am J Obstet Gynecol. 2015 Jan;212(1):50.e1-8
pubmed: 25046805
Reprod Health. 2018 May 8;15(1):75
pubmed: 29739429
Contraception. 2011 Jan;83(1):5-9
pubmed: 21134497
Br J Fam Plann. 1998 Apr;24(1):21-3
pubmed: 9719703
Int Fam Plan Perspect. 2005 Mar;31(1):15-23
pubmed: 15888405
BMC Womens Health. 2015 Nov 03;15:97
pubmed: 26530029
Front Psychol. 2013 Apr 10;4:179
pubmed: 23596433
Stud Fam Plann. 2017 Sep;48(3):269-278
pubmed: 28398595
PLoS One. 2015 Nov 02;10(11):e0141998
pubmed: 26524603
Reprod Health. 2018 Jun 26;15(1):114
pubmed: 29940996
Int J Gynaecol Obstet. 2012 Apr;117(1):5-9
pubmed: 22285856
Contraception. 2011 Mar;83(3):202-10
pubmed: 21310280
Int Perspect Sex Reprod Health. 2019 Nov 20;45:55-59
pubmed: 31751292
Contraception. 2006 Jun;73(6):594-7
pubmed: 16730490
Contraception. 2002 Jan;65(1):29-37
pubmed: 11861053